Skip to main content
FinSpry Logo
FinSpry
CRMD logo
CRMD
(NASDAQ)
CorMedix Inc.
$8.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CorMedix (CRMD) Stock Price & Financial Analysis

CorMedix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.65 - $8.85
52-Week High$16.89
52-Week Low$6.13
Open$8.84
Volume2.51M
Average Volume (3M)1.46M
Market Cap799.67M
Shares Outstanding92.98M
P/E Ratio (TTM)4.42
Forward P/E2.05
Price to Sales (P/S)2.00
Price to Book (P/B)1.83
EV/EBITDA3.62
Revenue (TTM)400.05M
Net Income (TTM)181.01M
Free Cash Flow (TTM)196.39M
EPS (TTM)$2.10
Profit Margin45.25%
Operating Margin48.41%
Return on Equity (ROE)41.42%
Debt to Equity0.33
50-Day MA$8.00
200-Day MA$9.12
52-Week Change-48.07%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About CorMedix

What is the current stock price for CRMD?

As of the latest trading session, CRMD stock trades at $8.67. The 52-week range is $6.13–$16.89, with a day range of $8.65–$8.85.

What is the P/E ratio for CRMD?

CorMedix's trailing P/E ratio is 4.4, meaning investors pay $4.4 for every $1 of annual earnings. The forward P/E is 2.0, reflecting analyst expectations for future earnings. CorMedix operates in the Healthcare sector.

Does CRMD pay dividends?

CorMedix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRMD?

Based on 7 analysts, the consensus for CRMD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRMD?

CorMedix's market capitalization is $806.2M, classifying it as a small-cap company. CorMedix operates in the Healthcare sector within the Biotechnology industry.